Potential Mechanisms Mediating Sustained Weight Loss Following Roux-en-Y Gastric Bypass and Sleeve Gastrectomy

Endocrinology and Metabolism Clinics of North America

Volumn 45, Issue 3, 2016, Pages 539-552

  Makaronidis, Janine M ^a,b   Batterham, Rachel L ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Bariatric surgery; Bile acids; Eating behavior; Gut hormones; Microbiome; Obesity; Roux en Y gastric bypass; Sleeve gastrectomy

Indexed keywords

BILE ACID; GASTROINTESTINAL HORMONE; GHRELIN; GLUCAGON LIKE PEPTIDE 1;

BEHAVIOR CHANGE; BODY MASS; CALORIC RESTRICTION; CLINICAL EFFECTIVENESS; DIGESTIVE TRACT PARAMETERS; ENTEROPLASTICITY; FEEDING BEHAVIOR; GASTRIC BYPASS SURGERY; HUMAN; INTERMETHOD COMPARISON; INTESTINE FLORA; MALABSORPTION; OBESITY; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; REVIEW; SLEEVE GASTRECTOMY; SURGICAL APPROACH; WEIGHT CONTROL; WEIGHT REDUCTION; BODY WEIGHT LOSS; CALORIC INTAKE; GASTRECTOMY; MORBID OBESITY;

ENERGY INTAKE; FEEDING BEHAVIOR; GASTRECTOMY; GASTRIC BYPASS; HUMANS; OBESITY, MORBID; WEIGHT LOSS;

EID: 84994410092     PISSN: 08898529     EISSN: 15584410     Source Type: Journal    
DOI: 10.1016/j.ecl.2016.04.006     Document Type: Review

References (76)

1. 1 Gloy, V.L., Briel, M., Bhatt, D.L., et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ, 347, 2013, f5934.
2. 2 Buchwald, H., Avidor, Y., Braunwald, E., et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 292:14 (2004), 1724–1737.
3. 3 Buchwald, H., Estok, R., Fahrbach, K., et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122:3 (2009), 248–256.e5.
4. 4 Miras, A.D., le Roux, C.W., Mechanisms underlying weight loss after bariatric surgery. Nat Rev Gastroenterol Hepatol 10:10 (2013), 575–584.
5. 5 Manning, S., Pucci, A., Batterham, R.L., Roux-en-Y gastric bypass: effects on feeding behavior and underlying mechanisms. J Clin Invest 125:3 (2015), 939–948.
6. 6 le Roux, C.W., Bueter, M., The physiology of altered eating behaviour after Roux-en-Y gastric bypass. Exp Physiol 99:9 (2014), 1128–1132.
7. 7 Saber, A.A., Elgamal, M.H., McLeod, M.K., Bariatric surgery: the past, present, and future. Obes Surg 18:1 (2008), 121–128.
8. 8 Buchwald, H., The evolution of metabolic/bariatric surgery. Obes Surg 24:8 (2014), 1126–1135.
9. 9 Mason, E.E., Ito, C., Gastric bypass in obesity. Surg Clin North Am 47:6 (1967), 1345–1351.
10. 10 Angrisani, L., Santonicola, A., Iovino, P., et al. Bariatric surgery worldwide 2013. Obes Surg 25:10 (2015), 1822–1832.
11. 11 Olbers, T., Lonroth, H., Fagevik-Olsen, M., et al. Laparoscopic gastric bypass: development of technique, respiratory function, and long-term outcome. Obes Surg 13:3 (2003), 364–370.
12. 12 Sjostrom, L., Review of the key results from the Swedish Obese Subjects (SOS) trial—a prospective controlled intervention study of bariatric surgery. J Intern Med 273:3 (2013), 219–234.
13. 13 Sjostrom, L., Peltonen, M., Jacobson, P., et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA 311:22 (2014), 2297–2304.
14. 14 Sczepaniak, J.P., Owens, M.L., Shukla, H., et al. Comparability of weight loss reporting after gastric bypass and sleeve gastrectomy using BOLD data 2008-2011. Obes Surg 25:5 (2015), 788–795.
15. 15 Carlin, A.M., Zeni, T.M., English, W.J., et al. The comparative effectiveness of sleeve gastrectomy, gastric bypass, and adjustable gastric banding procedures for the treatment of morbid obesity. Ann Surg 257:5 (2013), 791–797.
16. 16 Abu-Jaish, W., Rosenthal, R.J., Sleeve gastrectomy: a new surgical approach for morbid obesity. Expert Rev Gastroenterol Hepatol 4:1 (2010), 101–119.
17. 17 Schauer, P.R., Bhatt, D.L., Kirwan, J.P., et al. Bariatric surgery versus intensive medical therapy for diabetes–3-year outcomes. N Engl J Med 370:21 (2014), 2002–2013.
18. 18 Peterli, R., Steinert, R.E., Woelnerhanssen, B., et al. Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg 22:5 (2012), 740–748.
19. 19 Göteborg University, Sleeve gastrectomy and Roux-en-Y gastric bypass in the treatment of type 2 diabetes mellitus ClinicalTrials.gov. [Internet], 2015, National Library of Medicine (US), Bethesda (MD) Available at: https://clinicaltrials.gov/ct2/show/NCT01984762?term=Sleeve+Gastrectomy+and+Roux-en-Y+Gastric+Bypass+in+the+Treatment+of+Type+2+Diabetes+Mellitus&rank=1.
20. 20 Strasbourg, I.H.U., Laparoscopic sleeve gastrectomy versus Roux-en-Y gastric bypass ClinicalTrials.gov. 2015, National Library of Medicine (US), Bethesda (MD) Available at https://clinicaltrials.gov/ct2/show/record/NCT02475590?term=obesity+sleeve+gastrectomy+roux-en-y&rank=3.
21. 21 Suzuki, K., Jayasena, C.N., Bloom, S.R., Obesity and appetite control. Exp Diabetes Res, 2012, 2012, 824305.
22. 22 Morton, G.J., Meek, T.H., Schwartz, M.W., Neurobiology of food intake in health and disease. Nat Rev Neurosci 15:6 (2014), 367–378.
23. 23 Scott, W.R., Batterham, R.L., Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery. Am J Physiol Regul Integr Comp Physiol 301:1 (2011), R15–R27.
24. 24 Batterham, R.L., Cowley, M.A., Small, C.J., et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418:6898 (2002), 650–654.
25. 25 Batterham, R.L., ffytche, D.H., Rosenthal, J.M., et al. PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature 450:7166 (2007), 106–109.
26. 26 Manning, S., Pucci, A., Batterham, R.L., GLP-1: a mediator of the beneficial metabolic effects of bariatric surgery?. Physiology (Bethesda) 30:1 (2015), 50–62.
27. 27 Muller, T.D., Nogueiras, R., Andermann, M.L., et al. Ghrelin. Mol Metab 4:6 (2015), 437–460.
28. 28 Berthoud, H.R., Metabolic and hedonic drives in the neural control of appetite: who is the boss?. Curr Opin Neurobiol 21:6 (2011), 888–896.
29. 29 Dixon, J.B., Lambert, E.A., Lambert, G.W., Neuroendocrine adaptations to bariatric surgery. Mol Cell Endocrinol 418:Pt 2 (2015), 143–152.
30. 30 Seeley, R.J., Chambers, A.P., Sandoval, D.A., The role of gut adaptation in the potent effects of multiple bariatric surgeries on obesity and diabetes. Cell Metab 21:3 (2015), 369–378.
31. 31 Aron-Wisnewsky, J., Clement, K., The effects of gastrointestinal surgery on gut microbiota: potential contribution to improved insulin sensitivity. Curr Atheroscler Rep, 16(11), 2014, 454.
32. 32 Cummings, D.E., Taste and the regulation of food intake: it's not just about flavor. Am J Clin Nutr 102:4 (2015), 717–718.
33. 33 Browning, K.N., Fortna, S.R., Hajnal, A., Roux-en-Y gastric bypass reverses the effects of diet-induced obesity to inhibit the responsiveness of central vagal motoneurones. J Physiol 591:Pt 9 (2013), 2357–2372.
34. 34 Rissanen, A., Hakala, P., Lissner, L., et al. Acquired preference especially for dietary fat and obesity: a study of weight-discordant monozygotic twin pairs. Int J Obes Relat Metab Disord 26:7 (2002), 973–977.
35. 35 Shin, A.C., Townsend, R.L., Patterson, L.M., et al. “Liking” and “wanting” of sweet and oily food stimuli as affected by high-fat diet-induced obesity, weight loss, leptin, and genetic predisposition. Am J Physiol Regul Integr Comp Physiol 301:5 (2011), R1267–R1280.
36. 36 Sumithran, P., Prendergast, L.A., Delbridge, E., et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med 365:17 (2011), 1597–1604.
37. 37 Barkeling, B., King, N.A., Naslund, E., et al. Characterization of obese individuals who claim to detect no relationship between their eating pattern and sensations of hunger or fullness. Int J Obes (Lond) 31:3 (2007), 435–439.
38. 38 Leibel, R.L., Hirsch, J., Diminished energy requirements in reduced-obese patients. Metabolism 33:2 (1984), 164–170.
39. 39 Manning, S., Pucci, A., Carter, N.C., et al. Early postoperative weight loss predicts maximal weight loss after sleeve gastrectomy and Roux-en-Y gastric bypass. Surg Endosc 29:6 (2015), 1484–1491.
40. 40 Dirksen, C., Damgaard, M., Bojsen-Moller, K.N., et al. Fast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after Roux-en-Y gastric bypass. Neurogastroenterol Motil, 25(4), 2013 346–e255.
41. 41 Odstrcil, E.A., Martinez, J.G., Santa Ana, C.A., et al. The contribution of malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y gastric bypass. Am J Clin Nutr 92:4 (2010), 704–713.
42. 42 Lutz, T.A., Bueter, M., The physiology underlying Roux-en-Y gastric bypass: a status report. Am J Physiol Regul Integr Comp Physiol 307:11 (2014), R1275–R1291.
43. 43 Bray, G.A., Dahms, W.T., Atkinson, R.L., et al. Factors controlling food intake: a comparison of dieting and intestinal bypass. Am J Clin Nutr 33:2 Suppl (1980), 376–382.
44. 44 Warde-Kamar, J., Rogers, M., Flancbaum, L., et al. Calorie intake and meal patterns up to 4 years after Roux-en-Y gastric bypass surgery. Obes Surg 14:8 (2004), 1070–1079.
45. 45 Mathes, C.M., Spector, A.C., Food selection and taste changes in humans after Roux-en-Y gastric bypass surgery: a direct-measures approach. Physiol Behav 107:4 (2012), 476–483.
46. 46 Laurenius, A., Larsson, I., Bueter, M., et al. Changes in eating behaviour and meal pattern following Roux-en-Y gastric bypass. Int J Obes (Lond) 36:3 (2012), 348–355.
47. 47 Thomas, J.R., Marcus, E., High and low fat food selection with reported frequency intolerance following Roux-en-Y gastric bypass. Obes Surg 18:3 (2008), 282–287.
48. 48 Holinski, F., Menenakos, C., Haber, G., et al. Olfactory and gustatory function after bariatric surgery. Obes Surg 25:12 (2015), 2314–2320.
49. 49 Scholtz, S., Miras, A.D., Chhina, N., et al. Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding. Gut 63:6 (2014), 891–902.
50. 50 Miras, A.D., Jackson, R.N., Jackson, S.N., et al. Gastric bypass surgery for obesity decreases the reward value of a sweet-fat stimulus as assessed in a progressive ratio task. Am J Clin Nutr 96:3 (2012), 467–473.
51. 51 Ochner, C.N., Kwok, Y., Conceicao, E., et al. Selective reduction in neural responses to high calorie foods following gastric bypass surgery. Ann Surg 253:3 (2011), 502–507.
52. 52 Ochner, C.N., Stice, E., Hutchins, E., et al. Relation between changes in neural responsivity and reductions in desire to eat high-calorie foods following gastric bypass surgery. Neuroscience 209 (2012), 128–135.
53. 53 Shin, A.C., Berthoud, H.R., Obesity surgery: happy with less or eternally hungry?. Trends Endocrinol Metab 24:2 (2013), 101–108.
54. 54 Yousseif, A., Emmanuel, J., Karra, E., et al. Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans. Obes Surg 24:2 (2014), 241–252.
55. 55 Cummings, D.E., Weigle, D.S., Frayo, R.S., et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346:21 (2002), 1623–1630.
56. 56 Chandarana, K., Drew, M.E., Emmanuel, J., et al. Subject standardization, acclimatization, and sample processing affect gut hormone levels and appetite in humans. Gastroenterology 136:7 (2009), 2115–2126.
57. 57 Hosoda, H., Kangawa, K., Standard sample collections for blood ghrelin measurements. Meth Enzymol 514 (2012), 113–126.
58. 58 Ramon, J.M., Salvans, S., Crous, X., et al. Effect of Roux-en-Y gastric bypass vs sleeve gastrectomy on glucose and gut hormones: a prospective randomised trial. J Gastrointest Surg 16:6 (2012), 1116–1122.
59. 59 Dirksen, C., Jorgensen, N.B., Bojsen-Moller, K.N., et al. Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass. Int J Obes (Lond) 37:11 (2013), 1452–1459.
60. 60 le Roux, C.W., Welbourn, R., Werling, M., et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg 246:5 (2007), 780–785.
61. 61 Pucci, A., Wui Hang, C., Jenny, J., et al. A case of severe anorexia, excessive weight loss and high peptide YY levels after sleeve gastrectomy. Endocrinol Diabetes Metab Case Rep, 2015, 2015, 150020.
62. 62 Mathes, C.M., Bueter, M., Smith, K.R., et al. Roux-en-Y gastric bypass in rats increases sucrose taste-related motivated behavior independent of pharmacological GLP-1-receptor modulation. Am J Physiol Regul Integr Comp Physiol 302:6 (2012), R751–R767.
63. 63 Miras, A.D., le Roux, C.W., Bariatric surgery and taste: novel mechanisms of weight loss. Curr Opin Gastroenterol 26:2 (2010), 140–145.
64. 64 Mokadem, M., Zechner, J.F., Margolskee, R.F., et al. Effects of Roux-en-Y gastric bypass on energy and glucose homeostasis are preserved in two mouse models of functional glucagon-like peptide-1 deficiency. Mol Metab 3:2 (2014), 191–201.
65. 65 Ye, J., Hao, Z., Mumphrey, M.B., et al. GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents. Am J Physiol Regul Integr Comp Physiol 306:5 (2014), R352–R362.
66. 66 Chandarana, K., Gelegen, C., Karra, E., et al. Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YY. Diabetes 60:3 (2011), 810–818.
67. 67 Dutia, R., Embrey, M., O'Brien, S., et al. Temporal changes in bile acid levels and 12alpha-hydroxylation after Roux-en-Y gastric bypass surgery in type 2 diabetes. Int J Obes (Lond) 39:5 (2015), 806–813.
68. 68 Kuipers, F., Groen, A.K., FXR: the key to benefits in bariatric surgery?. Nat Med 20:4 (2014), 337–338.
69. 69 Watanabe, M., Houten, S.M., Mataki, C., et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439:7075 (2006), 484–489.
70. 70 Tremaroli, V., Karlsson, F., Werling, M., et al. Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metab 22:2 (2015), 228–238.
71. 71 Cavin, J.B., Couvelard, A., Lebtahi, R., et al. Differences in alimentary glucose absorption and intestinal disposal of blood glucose after Roux-en-Y gastric bypass vs sleeve gastrectomy. Gastroenterology 150:2 (2016), 454–464.e9.
72. 72 Sweeney, T.E., Morton, J.M., Metabolic surgery: action via hormonal milieu changes, changes in bile acids or gut microbiota? A summary of the literature. Best Pract Res Clin Gastroenterol 28:4 (2014), 727–740.
73. 73 le Roux, C.W., Aylwin, S.J., Batterham, R.L., et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 243:1 (2006), 108–114.
74. 74 Pournaras, D.J., Glicksman, C., Vincent, R.P., et al. The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology 153:8 (2012), 3613–3619.
75. 75 Rosenbaum, M., Knight, R., Leibel, R.L., The gut microbiota in human energy homeostasis and obesity. Trends Endocrinol Metab 26:9 (2015), 493–501.
76. 76 Leibel, R.L., Seeley, R.J., Darsow, T., et al. Biologic responses to weight loss and weight regain: report from an American Diabetes Association research symposium. Diabetes 64:7 (2015), 2299–2309.